Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 4/20 | 0.34 |
| ▸ | TET3 | O43151 | 1/20 | 0.34 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.33 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.33 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | GABRP | O00591 | 2/20 | 0.31 |
| ▸ | GABRD | O14764 | 2/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.31 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.31 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.31 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.31 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2048457 | 1.00 | TET2 (0.34) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL2045266 | 0.81 | TSHR (0.32) | — | |
| SCHEMBL13176643 | 0.78 | — | — | |
| SCHEMBL173083 | 0.78 | — | — | |
| SCHEMBL23251 | 0.78 | CA1 (0.48) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL18092214 | 0.76 | — | — | |
| SCHEMBL27792 | 0.76 | ALDH1A1 (0.45) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL15874792 | 0.75 | TSHR (0.32) | — | |
| Hydrochloric Acid SCHEMBL1961274 | 0.74 | ALDH1A1 (0.43) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL4929076 | 0.74 | TET2 (0.37) | TET2TET3TET1GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2324069-B1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | EVONIK ROEHM GMBH (DE) | 2013-12-18 | — | — | EP | claimed |
| US-20110144267-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | EVONIK ROEHM GMBH (DE) | 2011-06-16 | — | — | US | claimed |
| EP-2324069-A1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | Evonik Röhm GmbH (DE) | 2011-05-25 | — | — | EP | claimed |
| WO-2010026118-A1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | EVONIK RÖHM GMBH (DE) | 2010-03-11 | — | — | WO | claimed |
| EP-2321254-B1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | EVONIK ROEHM GMBH (DE) | 2014-07-30 | — | — | EP | disclosed |
| EP-2324069-B1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | EVONIK ROEHM GMBH (DE) | 2013-12-18 | — | — | EP | disclosed |
| EP-2324069-A1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | Evonik Röhm GmbH (DE) | 2011-05-25 | — | — | EP | disclosed |
| EP-2321254-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | Evonik Röhm GmbH (DE) | 2011-05-18 | — | — | EP | disclosed |
| WO-2010026204-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | EVONIK RÖHM GMBH (DE) | 2010-03-11 | — | — | WO | disclosed |
| WO-2010026118-A1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | EVONIK RÖHM GMBH (DE) | 2010-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144267-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | DNMT1, TET1, MGMT | TET2 8/4885TET3 5/4885TET1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.